<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Grafton-Clarke C</submitter><funding>Wellcome Trust</funding><pagination>e003081</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12060880</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Four-dimensional flow cardiovascular MRI (4D flow CMR) has emerged as a promising technique for assessing aortic stenosis (AS). This study aimed to evaluate the agreement between 4D flow CMR and transthoracic echocardiography (TTE) in estimating peak aortic valve (AV) velocities (V&lt;sub>Peak&lt;/sub>), grading AS severity and predicting AV intervention in a real-world setting.&lt;h4>Methods&lt;/h4>Participants from the PREFER-CMR registry who had consecutive TTE and 4D flow CMR were included. AS severity was graded using established protocols using three echocardiographic parameters (V&lt;sub>Peak&lt;/sub>, AV area and mean pressure gradient) and CMR-derived V&lt;sub>Peak&lt;/sub>.&lt;h4>Results&lt;/h4>The study recruited 30 patients (mean age 75.4 years, 67% male), with 17 undergoing AV intervention. Continuous wave Doppler (CWD) V&lt;sub>Peak&lt;/sub> (3.4 vs 2.6 m/s, p=0.0025) and 4D flow V&lt;sub>Peak&lt;/sub> (4.2 vs 2.7 m/s, p&lt;0.0001) were significantly higher in patients going for AV intervention. V&lt;sub>Peak&lt;/sub> by CWD was significantly lower to 4D flow with a bias of -0.5 (p=0.01) and a correlation of (R=0.55, p=0.002). The Cox-regression analysis reveals that 4D flow V&lt;sub>Peak&lt;/sub> significantly predicts AV intervention (HR=2.51, p&lt;0.01), while CWD V&lt;sub>Peak&lt;/sub> (HR=0.54, p=0.76) shows no significant association; overall model fit is significant (χ²=9.5, p=0.02).&lt;h4>Conclusion&lt;/h4>4D flow CMR-derived V&lt;sub>Peak&lt;/sub> assessment is superior to echocardiographic CWD assessment for predicting timing of AV intervention.&lt;h4>Trial registration number&lt;/h4>NCT05114785.</pubmed_abstract><journal>Open heart</journal><pubmed_title>Four-dimensional flow provides incremental diagnostic value over echocardiography in aortic stenosis.</pubmed_title><pmcid>PMC12060880</pmcid><funding_grant_id>205188/Z/16/Z</funding_grant_id><funding_grant_id>220703/Z/20/Z</funding_grant_id><pubmed_authors>Thampi K</pubmed_authors><pubmed_authors>Mehmood Z</pubmed_authors><pubmed_authors>Tsampasian V</pubmed_authors><pubmed_authors>Kasmai B</pubmed_authors><pubmed_authors>Curtin J</pubmed_authors><pubmed_authors>Yashoda GK</pubmed_authors><pubmed_authors>Broncano J</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Matthews G</pubmed_authors><pubmed_authors>Garg P</pubmed_authors><pubmed_authors>Hall R</pubmed_authors><pubmed_authors>Nair S</pubmed_authors><pubmed_authors>Swoboda P</pubmed_authors><pubmed_authors>Swift AJ</pubmed_authors><pubmed_authors>Vassiliou VS</pubmed_authors><pubmed_authors>Geest RJV</pubmed_authors><pubmed_authors>Assadi H</pubmed_authors><pubmed_authors>Staff L</pubmed_authors><pubmed_authors>Grafton-Clarke C</pubmed_authors><pubmed_authors>Ricci F</pubmed_authors><pubmed_authors>Alabed S</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Hewson D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Four-dimensional flow provides incremental diagnostic value over echocardiography in aortic stenosis.</name><description>&lt;h4>Aims&lt;/h4>Four-dimensional flow cardiovascular MRI (4D flow CMR) has emerged as a promising technique for assessing aortic stenosis (AS). This study aimed to evaluate the agreement between 4D flow CMR and transthoracic echocardiography (TTE) in estimating peak aortic valve (AV) velocities (V&lt;sub>Peak&lt;/sub>), grading AS severity and predicting AV intervention in a real-world setting.&lt;h4>Methods&lt;/h4>Participants from the PREFER-CMR registry who had consecutive TTE and 4D flow CMR were included. AS severity was graded using established protocols using three echocardiographic parameters (V&lt;sub>Peak&lt;/sub>, AV area and mean pressure gradient) and CMR-derived V&lt;sub>Peak&lt;/sub>.&lt;h4>Results&lt;/h4>The study recruited 30 patients (mean age 75.4 years, 67% male), with 17 undergoing AV intervention. Continuous wave Doppler (CWD) V&lt;sub>Peak&lt;/sub> (3.4 vs 2.6 m/s, p=0.0025) and 4D flow V&lt;sub>Peak&lt;/sub> (4.2 vs 2.7 m/s, p&lt;0.0001) were significantly higher in patients going for AV intervention. V&lt;sub>Peak&lt;/sub> by CWD was significantly lower to 4D flow with a bias of -0.5 (p=0.01) and a correlation of (R=0.55, p=0.002). The Cox-regression analysis reveals that 4D flow V&lt;sub>Peak&lt;/sub> significantly predicts AV intervention (HR=2.51, p&lt;0.01), while CWD V&lt;sub>Peak&lt;/sub> (HR=0.54, p=0.76) shows no significant association; overall model fit is significant (χ²=9.5, p=0.02).&lt;h4>Conclusion&lt;/h4>4D flow CMR-derived V&lt;sub>Peak&lt;/sub> assessment is superior to echocardiographic CWD assessment for predicting timing of AV intervention.&lt;h4>Trial registration number&lt;/h4>NCT05114785.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-02T21:01:32.278Z</modification><creation>2026-04-20T03:14:20.475Z</creation></dates><accession>S-EPMC12060880</accession><cross_references><pubmed>40340893</pubmed><doi>10.1136/openhrt-2024-003081</doi></cross_references></HashMap>